Actively Recruiting
Prospective Study of Gastroenteropancreatic Neuroendocrine Tumors Treated with Targeted Radionuclide Therapy Using PET-MRI Imaging and AI Analysis
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-09-22
80
Participants Needed
5
Research Sites
78 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients with gastroenteropancreatic neuroendocrine tumors GEP-NETs, a rare type of cancer affecting the digestive system. The study explores new ways to improve treatment with Peptide Receptor Radionuclide Therapy PRRT, using advanced imaging techniques and data analysis. It aims to identify early markers that predict how well PRRT will work by analyzing detailed imaging and molecular data from a large group of patients. Participants will undergo Simultaneous 68Ga-DOTATOC PET-MRI scans before starting PRRT, midway through treatment, and one year after beginning therapy. This advanced imaging combines PET and MRI to provide detailed pictures of tumors and their biological activity. The study also includes methods like genomic profiling and testing new radionuclides to improve patient selection and treatment effectiveness. During the study, patients will be monitored through scheduled PET-MRI scans and clinical evaluations to track response to PRRT over 18 months. Researchers will assess tumor progression or patient survival as primary outcomes. The study collects clinical, molecular, and imaging data to develop better predictive tools and improve personalized treatment strategies for patients with advanced GEP-NETs.
CONDITIONS
Brief Title
Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
Research Team
C
Catherine ANSQUER
L
Louis DE MESTIER
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here